Published in Psychiatry Res on October 30, 2000
Off-label indications for atypical antipsychotics: A systematic review. Ann Gen Hosp Psychiatry (2004) 0.92
Breast enlargement associated with low dose olanzapine. Indian J Pharmacol (2011) 0.91
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry (2005) 0.89
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine. Neuropsychiatr Dis Treat (2010) 0.87
Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study. Clin Pract Epidemiol Ment Health (2011) 0.79
Obsessive-compulsive spectrum disorders. Dialogues Clin Neurosci (2003) 0.75
Current management of obsessive and phobic states. Neuropsychiatr Dis Treat (2011) 0.75
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis (2000) 1.45
Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol (2008) 1.11
Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry Res (1999) 0.97
Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry (1995) 0.95
Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis. Clin Exp Rheumatol (2002) 0.86
Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys. Arch Virol (2007) 0.85
Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs). Psychopharmacol Bull (1996) 0.84
Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy. Tissue Antigens (2012) 0.80
[Post-partum as a specific risk factor for the onset of obsessive-compulsive disorder: clinical-controlled study]. Epidemiol Psichiatr Soc (2001) 0.79
Clinical features of dysthymia and age: a clinical investigation. Psychiatry Res (2001) 0.78
Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD). Psychopharmacol Bull (1996) 0.77
Type I and type II schizophrenia: relations between tonic electrodermal activity and clinical ratings before and after haloperidol treatment. Psychiatry Res (1995) 0.76
Recognition and treatment of dysthymia in elderly patients. Drugs Aging (2000) 0.75